Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 43 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Sinakos, Emmanouil  [Clear All Filters]
Journal Article
Momah, N., Silveira M. G., Jorgensen R., Sinakos E., & Lindor K. D. (2012).  Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis.. Liver Int. 32(5), 790-5.
Treeprasertsuk, S., Björnsson E., Sinakos E., Weeding E., & Lindor K. D. (2013).  Outcome of patients with primary sclerosing cholangitis and ulcerative colitis undergoing colectomy.. World J Gastrointest Pharmacol Ther. 4(3), 61-8.
Imam, M. H., Gossard A. A., Sinakos E., & Lindor K. D. (2012).  Pathogenesis and management of pruritus in cholestatic liver disease.. J Gastroenterol Hepatol. 27(7), 1150-8.
Sinakos, E., Selvaggi G., Papalavrentios L., Tzakis A., & Akriviadis E. (2011).  The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrence.. Ann Gastroenterol. 24(3), 228-230.
Paschos, P., Vlachaki E., Pasvanti C., Sinakos E., Kalpaka A., Klonizakis P., et al. (2011).  Safety and efficacy of combination therapy with pegylated interferon alpha-2a and ribavirin in treating patients with chronic hepatitis C and beta-thalassaemia major: a Greek single-center experience.. Acta Haematol. 126(4), 231-3.
Sinakos, E., Vlachaki E., & Tsapas A. (2012).  Safety of deferasirox in sickle cell disease patients with co-existing liver impairment.. Br J Haematol. 157(4), 505-6; author reply 506-7.
Sinakos, E., Dedes I., Papalavrentios L., Drevelegas A., & Akriviadis E. (2010).  Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma.. Scand J Gastroenterol. 45(4), 511-2.
Sinakos, E., Abbas G., Jorgensen R. A., & Lindor K. D. (2012).  Serum lipids in primary sclerosing cholangitis.. Dig Liver Dis. 44(1), 44-8.
Sinakos, E., Hytiroglou P., Stachteas P., Liava C., & Akriviadis E. (2019).  The significance of paired biopsies in estimating disease progression in patients with nonalcoholic steatohepatitis.. Eur J Gastroenterol Hepatol. 31(7), 897-898.
Televantou, D., Sinakos E., Akriviadis E. A., & Hytiroglou P. (2008).  Toxic hepatic injury mimicking ascending cholangitis: is Pyrus amygdaliformis to blame?. Virchows Arch. 453(4), 413-5.
Kalogirou, M., Chourmouzi D., Dedes I., Kiapidou S., Akriviadis E., & Sinakos E. (2018).  Transarterial embolization for the treatment of complicated liver hemangiomas: A report of two cases and review of the literature.. Clin Mol Hepatol. 24(3), 345-349.
Kalogirou, M., & Sinakos E. (2018).  Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?. World J Hepatol. 10(11), 790-794.
Akriviadis, E., & Sinakos E. (2016).  Treatment of alcoholic hepatitis: is this a "dead-end"?. Ann Gastroenterol. 29(2), 236-7.
Sinakos, E., Kountouras D., Koskinas J., Zachou K., Karatapanis S., Triantos C., et al. (2017).  Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.. Br J Haematol. 178(1), 130-136.
Sinakos, E., & Lindor K. (2010).  Treatment options for primary sclerosing cholangitis.. Expert Rev Gastroenterol Hepatol. 4(4), 473-88.
Tsaitas, C., Semertzidou A., & Sinakos E. (2014).  Update on inflammatory bowel disease in patients with primary sclerosing cholangitis.. World J Hepatol. 6(4), 178-87.
Papalavrentios, L., Sinakos E., Chourmouzi D., Hytiroglou P., Drevelegas K., Constantinides M., et al. (2015).  Value of 3 Tesla diffusion-weighted magnetic resonance imaging for assessing liver fibrosis.. Ann Gastroenterol. 28(1), 118-123.
Ali, A. H., Sinakos E., Silveira M. G., Jorgensen R. A., Angulo P., & Lindor K. D. (2011).  Varices in early histological stage primary biliary cirrhosis.. J Clin Gastroenterol. 45(7), e66-71.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.